Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice

Metabolomics

Volumn 3, Issue 2, 2007, Pages 137-145

  Wheelock, Craig E ^a,b,c   Goto, Susumu ^b   Hammock, Bruce D ^a   Newman, John W ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Clofibrate; Extra hepatic; Lipid metabolism; Metabolomics; PPAR alphaagonist; Sphingomyelin

Indexed keywords

MUS;

EID: 34249870602     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-007-0052-8     Document Type: Article

References (47)

1. Cailleret M., Amadou A., Andrieu-Abadie N., Nawrocki A., Adamy C., Ait-Mamar B., Rocaries F., Best-Belpomme M., Levade T., Pavoine C., Pecker F. (2004) N-acetylcysteine prevents the deleterious effect of tumor necrosis factor-(alpha) on calcium transients and contraction in adult rat cardiomyocytes. Circulation 109:406-411
2. Chen C., Hennig G.E., Whiteley H.E., Corton J.C., Manautou J.E. (2000) Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure. Toxicol. Sci. 57:338-344
3. Chinetti G., Lestavel S., Fruchart J.C., Clavey V., Staels B. (2003) Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages. Circ. Res. 92:212-217
4. Cook W.S., Yeldandi A.V., Rao M.S., Hashimoto T., Reddy J.K. (2000) Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha. Biochem. Biophys. Res. Commun. 278:250-257
5. Cremesti A.E., Goni F.M., Kolesnick R. (2002) Role of sphingomyelinase and ceramide in modulating rafts: Do biophysical properties determine biologic outcome? FEBS Lett. 531:47-53
6. Cullingford T.E., Dolphin C.T., Sato H. (2002) The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacology 42:724-730
7. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., Fruchart J.C., Tedgui A., Haegeman G., Staels B. (1999) Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274:32048-32054
8. Dolinsky V.W., Gilham D., Hatch G.M., Agellon L.B., Lehner R., Vance D.E. (2003) Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors. Biochim. Biophys. Acta 1635:20-28
9. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., Desvergne B. (2001) Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142:4195-4202
10. Finck B.N. (2004) The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart. Curr. Opin. Clin. Nutr. Metab. Care 7:391-396
11. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., Kelly D.P. (2003) A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc. Natl. Acad. Sci. USA 100:1226-1231
12. Folch J., Lees M., Sloane Stanley G.H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226:497-509
13. Fruchart J.C., Duriez P., Staels B. (1999) Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr. Opin. Lipidol. 10:245-257
14. Haag M. (2003) Essential fatty acids and the brain. Can. J. Psychiatry 48:195-203
15. Hamadeh H.K., Bushel P.R., Jayadev S., Martin K., DiSorbo O., Sieber S., Bennett L., Tennant R., Stoll R., Barrett J.C., Blanchard K., Paules R.S., Afshari C.A. (2002) Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67:219-231
16. Hatch G.M. (1994) Cardiolipin biosynthesis in the isolated heart. Biochem. J. 297(Pt 1):201-208
17. Hauser R., Meeker J.D., Park S., Silva M.J., Calafat A.M. (2004) Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Perspect. 112:1734-1740
18. Hauser R., Williams P., Altshul L., Calafat A.M. (2005) Evidence of interaction between polychlorinated biphenyls and phthalates in relation to human sperm motility. Environ. Health Perspect. 113:425-430
19. Jiang Y.J., Lu B., Xu F.Y., Gartshore J., Taylor W.A., Halayko A.J., Gonzalez F.J., Takasaki J., Choy P.C., Hatch G.M. (2004) Stimulation of cardiac cardiolipin biosynthesis by PPARalpha activation. J. Lipid Res. 45:244-252
20. Kainu T., Wikstrom A.C., Gustafsson J.A., Pelto-Huikko M. (1994) Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5:2481-2485
21. Karbowska J., Kochan Z., Zelewski L., Swierczynski J. (1999) Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expression. Eur. J. Pharmacol. 370:329-336
22. Kersten S., Desvergne B., Wahli W. (2000) Roles of PPARs in health and disease. Nature 405:421-424
23. Klaus S. (2004) Adipose tissue as a regulator of energy balance. Curr. Drug Targets 5:241-250
24. Kliewer S.A., Xu H.E., Lambert M.H., Willson T.M. (2001) Peroxisome proliferator-activated receptors: From genes to physiology. Recent Prog. Horm. Res. 56:239-263
25. Latini G., De Felice C., Verrotti A. (2004) Plasticizers, infant nutrition and reproductive health. Reprod Toxicol 19:27-33
26. Lee H.J., Mayette J., Rapoport S.I., Bazinet R.P. (2006) Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis 5:2
27. Lenart J., Komanska I., Jasinska R., Pikula S. (1998) The induction of cytochrome P450 isoform, CYP4A1, by clofibrate coincides with activation of ethanolamine-specific phospholipid base exchange reaction in rat liver microsomes. Acta Biochim. Pol. 45:119-126
28. Linton M.F., Fazio S. (2000) Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk. Curr. Atheroscler. Rep. 2:29-35
29. Maloney E.K., Waxman D.J. (1999) trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161:209-218
30. Marx N., Duez H., Fruchart J.C., Staels B. (2004) Peroxisome proliferator-activated receptors and atherogenesis: Regulators of gene expression in vascular cells. Circ. Res. 94:1168-1178
31. Matsuzaka T., Shimano H., Yahagi N., Amemiya-Kudo M., Yoshikawa T., Hasty A.H., Tamura Y., Osuga J., Okazaki H., Iizuka Y., Takahashi A., Sone H., Gotoda T., Ishibashi S., Yamada N. (2002) Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J. Lipid Res. 43:107-114
32. Michalik L., Desvergne B., Wahli W. (2004) Peroxisome-proliferator-activated receptors and cancers: Complex stories. Nat. Rev. Cancer 4:61-70
33. Miller C.W., Ntambi J.M. (1996) Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc. Natl. Acad. Sci. USA 93:9443-9448
34. Mortensen G.K., Main K.M., Andersson A.M., Leffers H., Skakkebaek N.E. (2005) Determination of phthalate monoesters in human milk, consumer milk, and infant formula by tandem mass spectrometry (LC-MS-MS). Anal. Bioanal. Chem. 382:1084-1092
35. Nakamura M.T., Nara T.Y. (2004) Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 24:345-376
36. Nemali M.R., Usuda N., Reddy M.K., Oyasu K., Hashimoto T., Osumi T., Rao M.S., Reddy J.K. (1988) Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 48:5316-5324
37. Otake T., Yoshinaga J., Yanagisawa Y. (2004) Exposure to phthalate esters from indoor environment. J. Expo. Anal. Environ. Epidemiol. 14:524-528
38. Reddy J.K. (2004) Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: Biotic and xenobiotic sensing. Am. J. Pathol. 164:2305-2321
39. Schlame M., Hostetler K.Y. (1997) Cardiolipin synthase from mammalian mitochondria. Biochim. Biophys. Acta 1348:207-213
40. Schmitz G., Langmann T. (2006) Pharmacogenomics of cholesterol-lowering therapy. Vascul. Pharmacol. 44:75-89
41. Song He W., Nara T.Y., Nakamura M.T. (2002) Delayed induction of delta-6 and delta-5 desaturases by a peroxisome proliferator. Biochem. Biophys. Res. Commun. 299:832-838
42. Sparagna G.C., Johnson C.A., McCune S.A., Moore R.L., Murphy R.C. (2005) Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J. Lipid Res. 46:1196-1204
43. Thorne P.C., Byers D.M., Palmer F.B., Cook H.W. (1994) Clofibrate and other peroxisomal proliferating agents relatively specifically inhibit synthesis of ethanolamine phosphoglycerides in cultured human fibroblasts. Biochim. Biophys. Acta 1214:161-170
44. Vincent P., Maneta-Peyret L., Cassagne C., Moreau P. (2001) Phosphatidylserine delivery to endoplasmic reticulum-derived vesicles of plant cells depends on two biosynthetic pathways. FEBS Lett. 498:32-36
45. Watkins S.M., Reifsnyder P.R., Pan H.J., German J.B., Leiter E.H. (2002) Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43:1809-1817
46. Xu Y., Kelley R.I., Blanck T.J., Schlame M. (2003) Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278:51380-51385
47. Zambon, A., Gervois, P., Pauletto, P., Fruchart, J.C. and Staels, B. (2006) Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-{alpha} activators. Clinical and Experimental Evidence. Arterioscler. Thromb. Vasc. Biol. 26(5):977-986